Catalyst Pharmaceuticals

YTD

ALL

Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CPRX

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.

CEO

Richard John Daly

CEORichard John Daly

Employees

181

Employees181

Headquarters

Coral Gables, Florida

HeadquartersCoral Gables, Florida

Founded

2002

Founded2002

Employees

181

Employees181

CPRX Key Statistics

Market cap

2.93B

Market cap2.93B

Price-Earnings ratio

17.38

Price-Earnings ratio17.38

Dividend yield

—

Dividend yield—

Average volume

1.60M

Average volume1.60M

High today

$23.10

High today$23.10

Low today

$23.10

Low today$23.10

Open price

$22.70

Open price$22.70

Volume

5.37K

Volume5.37K

52 Week high

$26.16

52 Week high$26.16

52 Week low

$14.47

52 Week low$14.47

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Catalyst Pharmaceuticals

Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Show more

CPRX Key Statistics

Analyst ratings

100%

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.